Surgical Resection Improves Survival in BCLC Stage C Hepatocellular Carcinoma

Share this content:

the Cancer Therapy Advisor take:

Surgical resection provides significantly better long-term survival compared to transarterial chemoembolization (TACE) in patients with advanced Barcelona Clinic Liver Cancer (BCLC) stage C hepatocellular carcinoma (HCC), according to a study published in the Journal of Surgical Oncology.

Taiwanese researchers led by Po-Hong Lui, MD, of the Taipei Veterans General Hospital examined patients being treated for their HCC, 264 with surgical resection and 389 with TACE. Among these patients, 163 matched pairs were identified from each arm by propensity score analysis in order to compare long-term survival.

They found that the group that underwent surgical resection had better liver function reserve than the TACE group, and demonstrated better long-term survival. After matched propensity modeling, baseline characteristics were similar between the two groups.

In addition, with Cox proportional modeling, patients who underwent TACE had an increased risk of mortality compared to those who underwent surgical resection.

“Multidisciplinary approaches for these patients and further amendments to the BCLC classification scheme are required,” the authors concluded.

Vandetanib May Not Be Effective for Advanced Biliary Tract Cancer
Surgical resection provides better survival compared to transarterial chemoembolization in hepatocellular carcinoma.
The authors aimed to compare surgical resection (SR) and transarterial chemoembolization (TACE) for advanced (BCLC stage C) hepatocellular carcinoma (HCC) patients. This study suggests that SR provides significantly better long-term survival than TACE in patients with BCLC stage C HCC, and should be an integral part in the management of advanced HCC.
READ FULL ARTICLE From Mdlinx

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs